In parallel, MMR-mutated human HCC cases in the TCGA cohort also showed significantly higher PD-1 gene expression (multivariate regression, p = 0.023, data not shown in the figure), supporting MMR mutations can distinguish immunogenic tumors that may show better survival upon ICI treatment among HCC. Here, MRC1 is linked to hepatocellular carcinoma.